Novonesis A/S

NSIS B

DK0060336014

Specialty Chemicals

Market Closed - Nasdaq Copenhagen Other stock markets 08:29:41 24/05/2024 pm IST			5-day change	1st Jan Change
424.1 ^DKK	-0.21%		-2.60%	+14.28%

10/05	NOVONESIS : Key segments outperform in average Q1 24 showing
03/05	Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024

Trading by management and close relations of management

May 08, 2024 at 06:52 pm IST

Please read the full announcement in PDF

Attachment

2024_16_Trading_By_Management

Latest news about Novonesis A/S

NOVONESIS : Key segments outperform in average Q1 24 showing	10/05
Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024	03/05
Novonesis Provides Sales Guidance for the Year 2024	03/05	CI
Novozymes A/S Approves Dividend for the Last Four Months Ended December 31, 2023	30/04	CI
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023	08/04	CI
China to speed up 'new productive forces', vice president says	26/03	RE
Nordic Shares Rose Thursday; Embracer Group Series B Topped Leaders	21/03	DJ
Transcript : Novozymes A/S, 2024 Guidance/Update Call, Mar 21, 2024	21/03
Novonensis expects 2024 adjusted EBITDA margin of 35%	21/03	RE
Novonesis Provides Earnings Guidance for the Year 2024	21/03	CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development	18/03	MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG	18/03	CI
FMC Partners With Novonesis in Canada for Biosolution Products	12/03	MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West	07/03	CI
Novozymes A/S Announces Board Appointments	04/03	CI
Transcript : Novozymes A/S - Shareholder/Analyst Call	04/03
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030	12/02	RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023	09/02	CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments	08/02
Novozymes, Chr. Hansen Complete Merger Settlement	02/02	MT
Transcript : Novozymes A/S, 2023 Earnings Call, Feb 01, 2024	01/02
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares	29/01	MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.	29/01	CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals	26/01	MT
Novozymes, Chr. Hansen Merger Wins Korean Regulatory Nod	20/12	MT

Novonesis A/S (formerly Novozymes A/S) is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (28.5%); - bioenergy (24.8%); - food industry and human health (22.1%); - technical and cereal industries (12.8%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the textile, leather, pulp and paper industries; - agriculture and animal feed industry (11.8%): enzymes used to improve the productivity and digestion of certain foods. Net sales are geographically distributed as follows: Denmark (1.3%), Europe/Middle East/Africa (33.5%), North America (33.9%), Asia/Pacific (18.5%) and Latin America (12.8%).

Sector

Specialty Chemicals

Calendar

18/06/2024 - Capital Markets Day

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

NOVONESIS : Key segments outperform in average Q1 24 showing

May 10, 2024 at 10:02 pm IST

More Strategies

Ratings for Novonesis A/S

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

424.1 DKK

Average target price

437.4 DKK

Spread / Average Target

+3.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Industrial Biotechnology Chemicals

	1st Jan change	Capi.
NOVONESIS A/S	+14.28%	28.66B
CATHAY BIOTECH INC.	-11.15%	3.92B
BORREGAARD ASA	+17.56%	1.9B
PUYANG HUICHENG ELECTRONIC MATERIAL CO., LTD.	-17.48%	589M
HENAN JINDAN LACTIC ACID TECHNOLOGY CO.,LTD.	-17.67%	429M
CHEMCON SPECIALITY CHEMICALS LIMITED	-16.30%	108M
I-TECH AB	-8.70%	56.37M

Industrial Biotechnology Chemicals

Novonesis A/S

Equities

NSIS B

DK0060336014

Specialty Chemicals

Trading by management and close relations of management

Latest news about Novonesis A/S

Chart Novonesis A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Novonesis A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Industrial Biotechnology Chemicals